NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Data Points Publication Series [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011-.
Figure 2Growth in number of beneficiaries treated with proton beam radiotherapy by facility, 2006-2009
OK=Oklahoma City, OK; TX=Houston, TX; SF=San Francisco, CA; MA=Boston, MA; LL=Loma Linda, CA; IN=Indianapolis, IN; FL=Gainesville, FL.
- Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.[Cancer. 2016]Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.Halpern JA, Sedrakyan A, Hsu WC, Mao J, Daskivich TJ, Nguyen PL, Golden EB, Kang J, Hu JC. Cancer. 2016 Aug 15; 122(16):2496-504. Epub 2016 May 25.
- Review Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.[J Manag Care Pharm. 2007]Review Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.Kilian J, Stubbings J. J Manag Care Pharm. 2007 Jan-Feb; 13(1):59-65.
- Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.[Fed Regist. 2003]Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.Centers for Medicare & Medicaid Services (CMS), HHS. Fed Regist. 2003 Dec 15; 68(240):69839-927.
- Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.[J Manag Care Spec Pharm. 2017]Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, Segal R. J Manag Care Spec Pharm. 2017 Jan; 23(1):13-21.
- Review Medicare Part D-a roundtable discussion of current issues and trends.[J Manag Care Pharm. 2009]Review Medicare Part D-a roundtable discussion of current issues and trends.Balfour DC 3rd, Evans S, Januska J, Lee HY, Lewis SJ, Nolan SR, Noga M, Stemple C, Thapar K. J Manag Care Pharm. 2009 Jan-Feb; 15(1 Suppl A):3-9.
- Figure 2, Growth in number of beneficiaries treated with proton beam radiotherap...Figure 2, Growth in number of beneficiaries treated with proton beam radiotherapy by facility, 2006-2009 - Data Points Publication Series
- CDH23-AS1 CDH23 antisense RNA 1 [Homo sapiens]CDH23-AS1 CDH23 antisense RNA 1 [Homo sapiens]Gene ID:102723377Gene
- NCRNA00223 AND (alive[prop]) (1)Gene
- NCRNA00223 (0)MeSH
- Autosomal recessive nonsyndromic hearing loss 12Autosomal recessive nonsyndromic hearing loss 12MedGen
Your browsing activity is empty.
Activity recording is turned off.
See more...